These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32061843)

  • 1. Nanocarriers as versatile delivery systems for effective management of acne.
    Patel R; Prabhu P
    Int J Pharm; 2020 Apr; 579():119140. PubMed ID: 32061843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioresponsive Nanoarchitectonics-Integrated Microneedles for Amplified Chemo-Photodynamic Therapy against Acne Vulgaris.
    Wen T; Lin Z; Zhao Y; Zhou Y; Niu B; Shi C; Lu C; Wen X; Zhang M; Quan G; Wu C; Pan X
    ACS Appl Mater Interfaces; 2021 Oct; 13(41):48433-48448. PubMed ID: 34613687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic resistance in the topical treatment of acne vulgaris.
    Leyden JJ
    Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous absorption and antibacterial activities of lipid nanocarriers loaded with dual drugs for acne treatment.
    Lin CH; Fang YP; Al-Suwayeh SA; Yang SY; Fang JY
    Biol Pharm Bull; 2013; 36(2):276-86. PubMed ID: 23370356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic Resistance in Acne Treatment.
    Adler BL; Kornmehl H; Armstrong AW
    JAMA Dermatol; 2017 Aug; 153(8):810-811. PubMed ID: 28636689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Rationally Designed Multifunctional Antibiotic for the Treatment of Drug-Resistant Acne.
    Ghosh S; Sinha M; Bhattacharyya A; Sadhasivam S; Megha J; Reddy S; Saini S; Singh H; Kumar D; Kaur SP; Mishra M; Usharani D; Ghosh S; Sengupta S
    J Invest Dermatol; 2018 Jun; 138(6):1400-1408. PubMed ID: 29409921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of oral antibiotics in treating acne vulgaris: a new approach.
    Farrah G; Tan E
    Dermatol Ther; 2016 Sep; 29(5):377-384. PubMed ID: 27306750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro Antimicrobial Activity of Acne Drugs Against Skin-Associated Bacteria.
    Blaskovich MAT; Elliott AG; Kavanagh AM; Ramu S; Cooper MA
    Sci Rep; 2019 Oct; 9(1):14658. PubMed ID: 31601845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolving Hyaluronic Acid-Based Microneedles to Transdermally Deliver Eugenol Combined with Photothermal Therapy for Acne Vulgaris Treatment.
    Wang Q; Gan Z; Wang X; Li X; Zhao L; Li D; Xu Z; Mu C; Ge L; Li D
    ACS Appl Mater Interfaces; 2024 May; 16(17):21595-21609. PubMed ID: 38635857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocolloidal carriers of isotretinoin: antimicrobial activity against Propionibacterium acnes and dermatokinetic modeling.
    Raza K; Singh B; Singla S; Wadhwa S; Garg B; Chhibber S; Katare OP
    Mol Pharm; 2013 May; 10(5):1958-63. PubMed ID: 23544848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in acne pathogenesis: implications for therapy.
    Das S; Reynolds RV
    Am J Clin Dermatol; 2014 Dec; 15(6):479-88. PubMed ID: 25388823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.
    Pollock B; Turner D; Stringer MR; Bojar RA; Goulden V; Stables GI; Cunliffe WJ
    Br J Dermatol; 2004 Sep; 151(3):616-22. PubMed ID: 15377348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical acne treatments in Europe and the issue of antimicrobial resistance.
    Leccia MT; Auffret N; Poli F; Claudel JP; Corvec S; Dreno B
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1485-92. PubMed ID: 25677763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
    Cunliffe WJ; Holland KT; Bojar R; Levy SF
    Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriological resistance in acne: A call to action.
    Dréno B
    Eur J Dermatol; 2016 Apr; 26(2):127-32. PubMed ID: 26711531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic-resistant acne: getting under the skin.
    Sinha M; Sadhasivam S; Bhattacharyya A; Jain S; Ghosh S; Arndt KA; Dover JS; Sengupta S
    Semin Cutan Med Surg; 2016 Jun; 35(2):62-7. PubMed ID: 27416310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers.
    Eady AE; Cove JH; Layton AM
    Am J Clin Dermatol; 2003; 4(12):813-31. PubMed ID: 14640775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Minocycline Foam 4%: A Review in Acne Vulgaris.
    Paik J
    Am J Clin Dermatol; 2020 Jun; 21(3):449-456. PubMed ID: 32468355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propionibacterium acnes and antimicrobial resistance in acne.
    Dessinioti C; Katsambas A
    Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hair Follicle-Targeted Delivery of Azelaic Acid Micro/Nanocrystals Promote the Treatment of Acne Vulgaris.
    Ji Y; Li H; Li J; Yang G; Zhang W; Shen Y; Xu B; Liu J; Wen J; Song W
    Int J Nanomedicine; 2024; 19():5173-5191. PubMed ID: 38855733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.